Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal + IPACK vs genicular nerve blocks for total knee arthroplasty
2025-523071-34-00Phase 4Authorised
- Sponsor
- IDIBAPS
- Start
- Feb 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of ropivacaine and epinephrine in knee osteoarthritis (OA) (2 arms), sponsored by IDIBAPS. Primary endpoint: Numerical Rating Scale (NRS) for pain. Planned start Feb 2026; status: authorised.
02
Drugs
ropivacaineepinephrine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2025-523071-34-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-523071-34-00.